Bone marrow histology in CALR mutated thrombocythemia and myelofibrosis: results from two cross sectional studies in 70 newly diagnosed JAK2/MPL wild type thrombocythemia patients
Open Access
- 21 June 2019
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 2 (1), 064-078
- https://doi.org/10.29328/journal.ijbmr.1001006
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- WHO Clinical Molecular and Pathological (WHO-CMP) Features of Congenital MPLS505N and the Acquired MPLW515l/K Mutated Essential Thrombocythemia and MyelofibrosisJournal of Hematology & Thromboembolic Diseases, 2014
- Somatic Mutations of Calreticulin in Myeloproliferative NeoplasmsThe New England Journal of Medicine, 2013
- The 2001 World Health Organization and Updated European Clinical and Pathological Criteria for the Diagnosis, Classification, and Staging of the Philadelphia Chromosome-Negative Chronic Myeloproliferative DisordersSeminars in Thrombosis and Hemostasis, 2006
- Clinical and Laboratory Features, Pathobiology of Platelet-Mediated Thrombosis and Bleeding Complications, and the Molecular Etiology of Essential Thrombocythemia and Polycythemia Vera: Therapeutic ImplicationsSeminars in Thrombosis and Hemostasis, 2006
- Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosisLeukemia, 2005
- A Unique Activating Mutation in JAK2 (V617F) Is at the Origin of Polycythemia Vera and Allows a New Classification of Myeloproliferative DiseasesHematology, 2005
- Proposal for Revised Diagnostic Criteria of Essential Thrombocythemia and Polycythemia Vera by the Thrombocythemia Vera Study GroupSeminars in Thrombosis and Hemostasis, 1997
- Chronic Myeloproliferative Disorders in Bone Marrow BiopsiesPathology - Research and Practice, 1990
- THE MANAGEMENT OF POLYCYTHAEMIA VERABritish Journal of Haematology, 1971
- PHYSIOPATHOLOGY AND COURSE OF POLYCYTHEMIA VERA AS RELATED TO THERAPYJournal of the American Medical Association, 1950